Literature DB >> 35463537

Outbreak control of hospital acquired varicella infection amongst health care workers in a tertiary care hospital.

Harpreet Singh1, Kapil H Pandya2, V K Bhatti3, Sumit Lathwal4, M Kumar5.   

Abstract

Background: Adult and immunocompromised patients suffering from varicella (chicken pox) are potential source of infection to healthcare workers. An outbreak of varicella among healthcare workers in a tertiary care centre was investigated, and preventive measures were implemented.
Methods: Cases of chicken pox between 05 Feb 2017 and 11 Feb 2017 in a tertiary healthcare establishment were investigated. An epidemiological investigation by developing case definitions, spot map and contact tracing was conducted. Eight cases were identified among healthcare workers. Suitable preventive measures including identification of susceptible contacts and vaccination of susceptible ones with two doses of varicella vaccine was undertaken.
Results: Index case was a 21-year-old nurse who was exposed to a 34-year-old male patient transferred from a secondary care hospital on 24 Jan 2017 as a case of acute liver failure and coagulopathy. Primary case was later diagnosed as case of varicella based on serological and clinical evidence. Among a total of 8 cases identified in the outbreak, the cases occurred among healthcare workers of secondary care centre, healthcare workers managing the primary case in the intensive care unit and who conducted the autopsy. A total of 181 contacts were identified in the epidemiological investigation, and 54 were susceptible to chicken pox. Two-dose immunization with varicella vaccination of susceptible ones was found to be effective in preventing further cases.
Conclusion: Two-dose vaccination of healthcare workers with varicella vaccine is an effective strategy to prevent nosocomial varicella among healthcare workers.
© 2022 Director General, Armed Forces Medical Services. Published by Elsevier, a division of RELX India Pvt. Ltd.

Entities:  

Keywords:  Healthcare workers; Outbreak; Vaccination; Varicella

Year:  2020        PMID: 35463537      PMCID: PMC9023553          DOI: 10.1016/j.mjafi.2019.12.004

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN: 0377-1237


  9 in total

1.  A cost benefit analysis of routine varicella vaccination in Spain.

Authors:  J Díez Domingo; M Ridao; J Latour; A Ballester; A Morant
Journal:  Vaccine       Date:  1999-03-17       Impact factor: 3.641

2.  An outbreak of cadaver-acquired chickenpox in a health care setting.

Authors:  Navin Paul; Mini E Jacob
Journal:  Clin Infect Dis       Date:  2006-07-27       Impact factor: 9.079

Review 3.  Varicella vaccines. WHO position paper.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  1998-08-07

4.  Varicella-zoster virus infection associated with acute liver failure.

Authors:  H Dits; E Frans; A Wilmer; M Van Ranst; J Fevery; H Bobbaers
Journal:  Clin Infect Dis       Date:  1998-07       Impact factor: 9.079

5.  Use of immunization as strategy for outbreak control of varicella zoster in an institutional setting.

Authors:  V K Bhatti; Lee Budhathoki; Mahadevan Kumar; Gurpreet Singh; Amol Nath; Gen Velu Nair
Journal:  Med J Armed Forces India       Date:  2014-06-24

6.  Chicken Pox with Multisystem Complications.

Authors:  N Bajaj; J Joshi; S Bajaj
Journal:  Med J Armed Forces India       Date:  2011-07-21

7.  An economic analysis of varicella vaccination for health care workers.

Authors:  A M Gray; P Fenn; J Weinberg; E Miller; A McGuire
Journal:  Epidemiol Infect       Date:  1997-10       Impact factor: 2.451

8.  Occupationally related outbreak of chickenpox in hospital staff: a learning experience.

Authors:  Smita Sood
Journal:  J Clin Diagn Res       Date:  2013-10-05

9.  Chickenpox-associated fulminant hepatitis that led to liver transplantation in a 63-year-old woman.

Authors:  Anne-Marie Roque-Afonso; Marie-Pierre Bralet; Philippe Ichai; Delphine Desbois; Parissa Vaghefi; Denis Castaing; Didier Samuel; Elisabeth Dussaix
Journal:  Liver Transpl       Date:  2008-09       Impact factor: 5.799

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.